Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19

The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and treatment wil...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Case Rep
Hoofdauteurs: Khatib, Mohamad Y., Shaik, Karimulla S., Ahmed, Amna A., Alwraidat, Mohammad A., Mohamed, Ahmed S., Abou Kamar, Mohamad R., Sharaf Eldean, Mouhammad Z., Aldaraiseh, Bashar K., Nashwan, Abdulqadir J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2020
Onderwerpen:
Case Reports
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813092/
https://ncbi.nlm.nih.gov/pubmed/33489151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3487
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items